Carl Maki to Protein Kinase Inhibitors
This is a "connection" page, showing publications Carl Maki has written about Protein Kinase Inhibitors.
Connection Strength
0.579
-
Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1. Cancer Biol Ther. 2014; 15(12):1600-12.
Score: 0.439
-
The IGF-1R/AKT pathway has opposing effects on Nutlin-3a-induced apoptosis. Cancer Biol Ther. 2017 Nov 02; 18(11):895-903.
Score: 0.140